Intranasal kennel cough vaccines
Infectious Canine Cough, commonly known as CIRDC, is a highly contagious respiratory disease. Found worldwide and easily communicable, it is estimated that almost 50% of canine infectious respiratory disease (CIRD) cases are probably transmitted outside the kennel.
Currently, fewer than 60% of routinely vaccinated dogs are also vaccinated against Infectious Canine Cough. Many of these vaccinated dogs only receive monovalent intranasal, injectable or an oral bordetella vaccine along with an injectable distemper, adenovirus type 2, parainfluenza, and parvovirus core vaccination. Recent studies suggest that core vaccines like these will not provide adequate protection against respiratory parainfluenza virus and adenovirus type 2 infections. And, just 14% of core-vaccinated dogs are also vaccinated against CIV (Canine Influenza Virus). With so few dogs adequately protected, Infectious Canine Cough continues to spread in places pet owners usually don’t suspect. And, as a result, a relatively high percentage of dogs will likely be affected in their lifetime.
Watch our video to see how to give intranasal kennel cough vaccines.
Nobivac’s intranasal kennel cough vaccines (Nobivac Intra-Trac KC, Nobivac Intra-Trac 3 and Nobivac Intra-Trac 3 ADT) offer efficacious protection with a fast onset of immunity. Merck Animal Health also offers injectable canine influenza vaccines as an aid in the control of disease associated with canine influenza H3N8 and H3N2 infection. Contact your local Merck Animal Health organization for more information.
Source: GFK Market Research 2014 - Dispensed Doses
Source: Estimate based on a telephone survey of UK vets' recent cases, Intervet/Schering-Plough. Nov 2009